| Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity Kenji Chamotoa,1, Partha S. Chowdhurya,1, Alok Kumara, Kazuhiro Sonomurab,c ... PNAS, 2017 | 366* | 2017 |
| PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8+ T Cells and Facilitates Anti–PD-1 Therapy PS Chowdhury, K Chamoto, A Kumar, T Honjo Cancer immunology research 6 (11), 1375-1387, 2018 | 254 | 2018 |
| Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy A Kumar, K Chamoto, PS Chowdhury, T Honjo Elife 9, e52330, 2020 | 50 | 2020 |
| Immune metabolism in PD-1 blockade-based cancer immunotherapy A Kumar, K Chamoto International immunology 33 (1), 17-26, 2021 | 33 | 2021 |
| A combination of linalool, vitamin C, and copper synergistically triggers reactive oxygen species and DNA damage and inhibits Salmonella enterica subsp. enterica Serovar Typhi … T Ghosh, SK Srivastava, A Gaurav, A Kumar, P Kumar, AS Yadav, ... Applied and Environmental Microbiology 85 (4), e02487-18, 2019 | 33 | 2019 |
| Targeted suppression of metastasis regulatory transcription factor SOX2 in various cancer cell lines using a sequence-specific designer pyrrole–imidazole polyamide M Malinee, A Kumar, T Hidaka, M Horie, K Hasegawa, GN Pandian, ... Bioorganic & Medicinal Chemistry 28 (3), 115248, 2020 | 23 | 2020 |
| Aptamer technology for the detection of foodborne pathogens and toxins A Kumar, M Malinee, A Dhiman, A Kumar, TK Sharma Advanced biosensors for health care applications, 45-69, 2019 | 19 | 2019 |
| Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors K Lontos, Y Wang, SK Joshi, AT Frisch, MLJ Watson, A Kumar, AV Menk, ... Journal for Immunotherapy of Cancer 11 (3), 2023 | 18 | 2023 |
| Nanomedicine: diagnosis, treatment, and potential prospects M Bansal, A Kumar, M Malinee, TK Sharma Nanoscience in Medicine Vol. 1, 297-331, 2020 | 12 | 2020 |
| Aptamer-mediated Nanobiosensing for health monitoring M Malinee, A Kumar, A Dhiman, TK Sharma Advanced Biosensors for Health Care Applications, 227-248, 2019 | 12* | 2019 |
| Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology K Lontos, Y Wang, M Colbert, A Kumar, S Joshi, M Philbin, Y Wang, ... OncoImmunology 11 (1), 2131229, 2022 | 3 | 2022 |
| Mitochondrial Manipulation Improves Anti-Tumor Immunity MM Alok Kumar Acta Scientific Cancer Biology 3 (12), 28-30, 2019 | 3 | 2019 |
| Trending approaches in electrospinning and electrospraying for biomedical applications P Dubey, I Matai, D Garg, A Kumar, V Takiar Biomedical Applications of Electrospinning and Electrospraying, 333-354, 2021 | 1 | 2021 |
| Redox and detox: Malate shuttle metabolism keeps exhausted T cells fit A Kumar, GM Delgoffe Cell Metabolism 35 (12), 2101-2103, 2023 | | 2023 |
| Role of Nanoparticles in Cancer Immunotherapy M Malinee, A Kumar Bionanotechnology in Cancer, 495-526, 2022 | | 2022 |
| Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy K Alok Kyoto University, 2020 | | 2020 |
| Blocking energy production in immune cells helps tumours escape treatment A Kumar https://medicalxpress.com/news/2020-03-blocking-energy-production-immune …, 2020 | | 2020 |
| Inhibiting energy production in immune T-cells allows some tumors to escape treatment A Kumar https://www.news-medical.net/news/20200303/Inhibiting-energy-production-in …, 2020 | | 2020 |
| Blocking energy production in immune cells helps tumours escape treatment A Kumar https://www.eurekalert.org/pub_releases/2020-03/e-bep030320.php, 2020 | | 2020 |
| T cell mitochondria dysregulation by tumor-derived immunosuppressive factors induces unresponsiveness to the PD-1 blockade cancer immunotherapy. A Kumar Newsletter, 2019 [RI Center, Kyoto University] 63, p: 4-7, 2019 | | 2019 |
partha s. chowdhurypost doctoral fellow在 mfour.med.kyoto-u.ac.jp 的电子邮件经过验证
